CASE CCC IN THE NEWS
Study: PCa screening reduces advanced cancer risk
ModernMedicine-Sep 5, 2012
... of developing advanced cancer, which is associated with additional treatment-related costs and morbidity," said first author Jay P. Ciezki, MD.
FUNDING OPPORTUNITIES
American Cancer Society
The American Cancer Society is accepting applications for the following funding opportunities:
- Area of Special Interest: The Role of Healthcare and Insurance in Improving Outcomes in Cancer Prevention, Early Detection and Treatment: The ACS invites applications that investigate the impact of healthcare costs, healthcare system and capacity, insurance status, social factors and delivery of health care services, on outcomes in cancer prevention, early detection and treatment. The purpose of these awards is to stimulate research on the effects of the US healthcare system structure and the role of insurance on access to screenings and treatment. Of particular interest is research using linked databases such as SEER, Medicare payment data, State data and NCHS data or other existing databases. Studies may be at the state, multi-state, or national levels, or otherwise involve large populations. Respondents should specifically describe how their results will generalize to the broader corresponding U.S. populations.
Deadline: October 15
- RFA: Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families: In an effort to support clinician investigators conducting patient-oriented research in palliative care, the ACS, in parallel with the National Palliative Care Research Center, is soliciting applications for pilot/exploratory research grants in palliative care of cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator's chances of competing successfully for larger grants. This RFA provides funding for investigators performing pilot and exploratory research studies whose purpose is to test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families. A condition of funding is a clearly defined plan as to how the investigator will use the results of the project to develop larger, extramurally funded research projects.
Deadline: October 15
- Priority Focus in Cancer Control and Prevention Research Program: Health Disparities Research: The ACS is committed to reducing cancer health disparities and has created strategic priorities for eliminating such disparities through research, education, advocacy and service. The ACS has set as a Nationwide Objective the goal of eliminating disparities in cancer burdens by 2015. Towards this goal, the Extramural Research and Training Grants (EG) Department has made the reduction of cancer health disparities a priority area of focus for the Cancer Control and Prevention Research Program with a call for applications in psychosocial and behavioral research and in health policy and health services research that address cancer health disparities. Within the Cancer Control and Prevention Research Program (one of five research programs in the EG department), meritorious applications focusing on disparity reduction will be funded prior to meritorious applications focusing on other areas in cancer control and prevention research. In order to qualify for the Priority Program, the application must explicitly demonstrate its relevance to cancer disparities and specify how the results of the proposed study can be used to reduce disparities.
Deadline: October 15
Alex's Lemonade Stand Foundation Springboard Grant Program
Alex's Lemonade Stand Foundation Springboard Grant is designed to support new NIH R01 or P01 research projects which were scored less than or equal to the 20th percentile but were not funded. ALSF will support projects via this mechanism for a maximum of 12 months. If NIH funding is secured and begins before the end of this 12 month period, ALSF must be notified and will cease its financial support of the project. Projects funded via this mechanism that do not receive funding from the NIH within 12 months are not eligible to reapply for the ALSF Springboard Grant.
Deadline: October 29
ANNOUNCEMENTS
Clinical Assay Development Program
The NCI Clinical Assay Development Program (CADP) is accepting applications from investigators seeking clinical assay validation resources. These resources are designed to assist with the development of assays that may predict therapy response or prognostic behavior of a diagnosed cancer, primarily for use in clinical trials. Approved projects for the NCI CADP will be provided access to the Institute's assay development and validation resources, including project management support.
When applying to the CADP, it is important that investigators define the intended clinical use for the assays for which support is requested. Assays submitted for CADP development services should have been tested on human tissue.
Deadline: October 15
NCI CANCER BULLETIN
September 4, 2012
News
Featured Article: Genome Study Points to Treatments for High-Risk Form of Childhood Leukemia
High Breast Density Does Not Predict Death among Breast Cancer Patients
Flavored Cigar Use Common among Young Adult Cigar Smokers
Gene in Stem Cell Donors May Decrease Relapse Risk in Leukemia Patients
Sequencing "Outlier" Genome Suggests Some Patients May Benefit from Cancer Drug
Researchers Use Gene Deletions to Find Cancer Treatment Targets
Also in the News: CDC Updates Hepatitis C Testing Recommendations
Also in the Journals: Youth Tobacco Use Dropped between 2000 and 2011
Commentary
A Conversation with Dr. Louis Staudt about Targeting New Treatments for Burkitt Lymphoma
In Depth
Clinical Pathways in Cancer Care Catching On
Featured Clinical Trial: Targeting Invasive Glioma Cells
Updates
FDA Update
Cancer.gov Update
Notes
| EVENTS
September 10
Pathology Research Seminar Series
Trever Bivona, MD, PhD
Assistant Professor, Hematology and Oncology
University of California, San Francisco
Topic: Genome-wide Approaches to Optimize Molecularly-targeted Cancer Therapy
12 pm WRB 1-413
Physiology and Biophysics Seminar
Sharon Campbell, PhD
Professor, Biochemistry and Biophysics
University of North Carolina
Topic: Ubiquitin and Redox-mediated Posttranslational Modification of Ras Regulates Ras Activity
4 pm SOM / Robbins Building, E-501
Skeletal Research Center Weekly Seminar Series
Patrick Leahy, PhD
Assistant Professor, Div. of General Medical Sciences-Oncology
Director, Laser Capture Microdissection Service, Gene Expression and Genotyping Facility
CWRU
AND
Nicholas Beckloff, PhD
Instructor, Genetics
Director, Genomics Core Facility
CWRU
Topic: Introduction to the Deep Sequencing Capability at Case Western
4 pm Millis 123
September 11
Pharmacology Invited Seminar
Anthony Wynshaw-Boris, MD, PhD
Professor, Human Genetics and Pediatrics
Chief, Div. of Medical Genetics
University of California, San Francisco
Topic: Modeling Human Neurogenetic Disorders- From Pathogenesis to Therapies
1 pm Webster Conference Rm, W331
September 12
Hematology and Oncology Division Research Conference
Panos Savvides, MD, PhD
Assistant Professor, Div. of Hem/Onc
CWRU/UH
Topic: Head and Neck Cancer
8 am Lerner Tower B-151
Immunology Invited Speaker Seminar Series
Richard Ransohoff, MD
Director, Neuroinflammation Research Center
Cleveland Clinic
Topic: Telling Monocytes from Microglia in the Inflamed Brain: How, Why and What was Learned
12 pm NC1-202 Cleveland Clinic
September 13
Stem Cell Biology and Regenerative Medicine
Damien Reynaud, PhD
Postdoctoral Fellow, Eli and Edythe Broad Center of Regeneration Medicine
University of California, San Francisco
Topic: Cell Hierarchy and Differentiation Pathways Defining Leukemic Hematopoiesis
1 pm NE1-205
September 14
Taussig Cancer Institute Grand Rounds will resume in September
Hematology/Oncology Fellows Conference/Curriculum Series
Topic: TBD
8 am Wearn 137
Cancer Center Seminar Series
Justin Lathia, PhD
Assistant Professor, Cell Biology
CWRU/Cleveland Clinic
Topic: Holding on to Stemness: Maintenance of the Glioblastoma Cellular Hierarchy by Microenvironmental Adhesion Mechanisms
12 pm Frohring Auditorium – BRB 105
Cancer Center Research in Progress
David Askew, PhD
Senior Research Associate, Cooke Lab, Pediatrics- Hem/Onc
Topic: A Novel Role for Cdk5 in T Cell Activation and Migration During Graft-Versus-Host Reactions Following Allogeneic BMT
4 pm WRB 3-136
Case CCC Calendar
LRI Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Imaging Solutions in Cancer Management: A Case-based Conference
September 21
Wolstein Research Building
Brochure
Registration
National GvHD Health Symposium
November 2
Embassy Suites Cleveland-Rockside
Details
Registration
ADDITIONAL UPCOMING SEMINARS & EVENTS
NCI Office of Cancer Centers Learning Series Webinar: Complementary and Alternative Medicine Cancer Research and the National Cancer Institute
September 11
2-3:30 pm
Registration
Ninth International Conference of the Society for Integrative Oncology
October 8-10
Albuquerque, NM
Details
Biennial Science of Global Prostate Cancer Disparities conference
November 1-4
Nassau, The Bahamas
Details
The Cancer Genome Atlas 2nd Annual Scientific Symposium: Enabling Cancer Research Through TCGA
November 27-28
Crystal City, Virginia
Details
Deadline to submit abstracts: October 5
American Society of Hematology (ASH) Annual Meeting
December 8-11
Atlanta, Georgia
Details
Pacific Symposium on Biocomputing 2013
January 3-7, 2013
Fairmont Orchid, Hawaii
Details
|
